List of Tables
    Table 1. Receptor Tyrosine Protein Kinase ERBB 3 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
    Table 3. Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers
    Table 4. Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
    Table 5. Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
    Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturer, 2017-2022
    Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2021)
    Table 18. Top Players of Receptor Tyrosine Protein Kinase ERBB 3 in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
    Table 20. Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Receptor Tyrosine Protein Kinase ERBB 3 Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Plc Corporation Information
    Table 43. AstraZeneca Plc Description and Business Overview
    Table 44. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
    Table 46. AstraZeneca Plc Recent Development
    Table 47. AVEO Pharmaceuticals, Inc. Corporation Information
    Table 48. AVEO Pharmaceuticals, Inc. Description and Business Overview
    Table 49. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. AVEO Pharmaceuticals, Inc. Product
    Table 51. AVEO Pharmaceuticals, Inc. Recent Development
    Table 52. Etubics Corporation Corporation Information
    Table 53. Etubics Corporation Description and Business Overview
    Table 54. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Etubics Corporation Product
    Table 56. Etubics Corporation Recent Development
    Table 57. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 58. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 59. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. F. Hoffmann-La Roche Ltd. Product
    Table 61. F. Hoffmann-La Roche Ltd. Recent Development
    Table 62. GamaMabs Pharma S.A. Corporation Information
    Table 63. GamaMabs Pharma S.A. Description and Business Overview
    Table 64. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. GamaMabs Pharma S.A. Product
    Table 66. GamaMabs Pharma S.A. Recent Development
    Table 67. GlaxoSmithKline Plc Corporation Information
    Table 68. GlaxoSmithKline Plc Description and Business Overview
    Table 69. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Plc Product
    Table 71. GlaxoSmithKline Plc Recent Development
    Table 72. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
    Table 73. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
    Table 74. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Hanmi Pharmaceuticals, Co. Ltd. Product
    Table 76. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
    Table 77. ImmunoGen, Inc. Corporation Information
    Table 78. ImmunoGen, Inc. Description and Business Overview
    Table 79. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. ImmunoGen, Inc. Product
    Table 81. ImmunoGen, Inc. Recent Development
    Table 82. Kolltan Pharmaceuticals, Inc. Corporation Information
    Table 83. Kolltan Pharmaceuticals, Inc. Description and Business Overview
    Table 84. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Kolltan Pharmaceuticals, Inc. Product
    Table 86. Kolltan Pharmaceuticals, Inc. Recent Development
    Table 87. Merrimack Pharmaceuticals, Inc. Corporation Information
    Table 88. Merrimack Pharmaceuticals, Inc. Description and Business Overview
    Table 89. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Merrimack Pharmaceuticals, Inc. Product
    Table 91. Merrimack Pharmaceuticals, Inc. Recent Development
    Table 92. Merus B.V. Corporation Information
    Table 93. Merus B.V. Description and Business Overview
    Table 94. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Merus B.V. Product
    Table 96. Merus B.V. Recent Development
    Table 97. Novartis AG Corporation Information
    Table 98. Novartis AG Description and Business Overview
    Table 99. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Novartis AG Product
    Table 101. Novartis AG Recent Development
    Table 102. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
    Table 103. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
    Table 104. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product
    Table 106. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
    Table 107. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
    Table 108. Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
    Table 109. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Sihuan Pharmaceutical Holdings Group Ltd. Product
    Table 111. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
    Table 112. Sorrento Therapeutics, Inc. Corporation Information
    Table 113. Sorrento Therapeutics, Inc. Description and Business Overview
    Table 114. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Sorrento Therapeutics, Inc. Product
    Table 116. Sorrento Therapeutics, Inc. Recent Development
    Table 117. Symphogen A/S Corporation Information
    Table 118. Symphogen A/S Description and Business Overview
    Table 119. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Symphogen A/S Product
    Table 121. Symphogen A/S Recent Development
    Table 122. Takis S.r.l. Corporation Information
    Table 123. Takis S.r.l. Description and Business Overview
    Table 124. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Takis S.r.l. Product
    Table 126. Takis S.r.l. Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
    Table 130. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Product Picture
    Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2017-2028 (US$ Million)
    Figure 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2028 (K Pcs)
    Figure 5. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2017-2028 (US$ Million)
    Figure 7. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2028 (K Pcs)
    Figure 8. United States Receptor Tyrosine Protein Kinase ERBB 3 Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Receptor Tyrosine Protein Kinase ERBB 3 Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Receptor Tyrosine Protein Kinase ERBB 3 Report Years Considered
    Figure 11. Product Picture of BA-0702
    Figure 12. Product Picture of CDX-3379
    Figure 13. Product Picture of Elgemtumab
    Figure 14. Product Picture of ETBX-031
    Figure 15. Product Picture of Others
    Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type in 2022 & 2028
    Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028) & (K Pcs)
    Figure 20. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2017-2028) & (USD/Pcs)
    Figure 22. United States Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type in 2022 & 2028
    Figure 23. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028) & (K Pcs)
    Figure 26. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2017-2028) & (USD/Pcs)
    Figure 28. Product Picture of Non-Small Cell Carcinoma
    Figure 29. Product Picture of Solid Tumor
    Figure 30. Product Picture of Melanoma
    Figure 31. Product Picture of Colorectal Cancer
    Figure 32. Product Picture of Others
    Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application in 2022 & 2028
    Figure 34. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028) & (K Pcs)
    Figure 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. United States Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application in 2022 & 2028
    Figure 40. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028) & (K Pcs)
    Figure 43. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2017-2028) & (USD/Pcs)
    Figure 45. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 50. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 57. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 74. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Receptor Tyrosine Protein Kinase ERBB 3 Value Chain
    Figure 79. Receptor Tyrosine Protein Kinase ERBB 3 Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed